Abstract
The anticancer activity of monensic acid (MonH) and its biometal(II) complexes [M(Mon)2(H2O)2](M = Mg, Ca, Mn, Co, Ni, Zn) was evaluated against cultured human permanent cell lines established from glioblastoma multiforme (8MGBA) and cancers of the lung (A549), breast (MCF-7), uterine cervix (HeLa) and liver (HepG2). The viability and proliferation of the non-tumor human embryonic cell line Lep3 was also tested. The investigations were carried out using a thiazolyl blue tetrazolium bromide test, neutral red uptake cytotoxicity assay, crystal violet staining, colony forming method and double staining with acridin orange and propidium iodide. The results obtained reveal that the compounds applied at concentrations of 0.5–25 µg mL−1 for 24–72 h decrease the viability and proliferation of the treated cells in a time- and concentration-dependent manner. The metal(II) complexes studied (especially those of Co(II), Ni(II) and Zn(II)) have been found to express stronger cytotoxic and cytostatic activities than the non-coordinated monensic acid. The non-tumor human cell line showed strong chemosensitivity towards compounds tested comparable to that of cultured human tumor cell lines.
Similar content being viewed by others
References
A. Agtarap, J.W. Chamberlin, M. Pinkerton, L.K. Steinrauf, J. Am. Chem. Soc. 89, 5737 (1967)
B.C. Pressman, Ann. Rev. Biochem. 45, 501 (1976)
P.H. Stern, Clin. Orthop. Rel. Res. 122, 273 (1977)
P.C. Augustine, C.K. Smith, H.D. Danforth, M.D. Ruff, Poultry Sci. 66, 960 (1987)
S.D. Folz, B.L. Lee, L.H. Nowakowski, G.A. Conder, Vet. Parasit. 28, 1 (1988)
D.A. Kevin II, D.A.F. Meujo, M.T. Hamann, Exp. Opi. Drug Discov. 4, 109 (2009)
B.G. Cox, N. van Truong, J. Rzeszotarska, H. Schneider, J. Chem. Soc., Faraday Trans. I 80, 3275 (1984)
M. Mimouni, S. Perrier, I. Pointud, J. Juillard, J. Sol. Chem. 22, 769 (1993)
M. Mimouni, M. Hebrant, G. Dauphin, J. Juillard, J. Chem. Res. S6, 278 (1996)
F.G. Riddell, Chirality 14, 121 (2002)
W.H. Park et al., Intern. J. Cancer 101, 235 (2002)
W.H. Park et al., Brit. J. Haem. 119, 400 (2002)
W.H. Park et al., Intern. J. Oncol. 22, 377 (2003)
W.H. Park et al., Intern. J. Oncol. 22, 855 (2003)
W.H. Park, E.S. Kim, B.K. Kim, Y.Y. Lee, Intern. J. Oncology 23, 197 (2003)
J. Basque, M. Martel, R. Leduc, A.M. Cantin, Can. J. Physiol. Pharmacol. 86, 606 (2008)
G.C. Blobe, W.P. Schiemann, H.F. Lodish, N. Engl. J. Med. 342, 1350 (2000)
T. Griffin et al., J. Natl. Cancer Inst. 85, 292 (1993)
M.S. Shaik, T.L. Jackson, M. Singh, J. Pharm. Pharmacol. 55, 819 (2003)
M. Wu, Br. J. Cancer. 75, 1347 (1997)
M. Sehested, T. Skovsgaard, H. Roed, Biochem. Pharmacol. 37, 3305 (1988)
W.D. Klohz, R.W. Steinkampf, Mol. Pharmacol. 34, 180 (1988)
N.K. Chirase, L.W. Greene, G.T. Schelling, F.M. Byers, J. Anim. Sci. 65, 1633 (1987)
K.A. Johnson, Diss. Abstr., Intern. B Sci. Eng. 48, 1855 (1988)
S.A. Hamidinia et al., J. Biol. Chem. 277, 38111 (2002)
I.N. Pantcheva et al., Curr. Drug Discov. Techn. 5, 154 (2008)
I.N. Pantcheva et al., BioMetals 23, 59 (2010)
I.N. Pantcheva et al., Inorg. Chim. Acta 363, 1879 (2010)
J. Ivanova et al., Centr. Eur. J. Chem. 8, 852 (2010)
R.I. Alexandrova, T. Zhivkova, I.N. Pantcheva, M.Io. Mitewa, Intern. J. Biol. Biomed. Eng. 5, 93 (2011)
M. R. Boyd, In: B. Teicher (Ed.), Anticancer Drug Development Cuide: Preclinical Screening, Clinical Trials and Approval (Humana Press Inc., Totowa, NJ, 1995) 23
A. Perzelova et al., Neoplasma 42, 25 (1998)
T. Mosmann, J. Immunol. Meth. 65, 55 (1983)
E. Borenfreund, J. Puerner, Toxicol. Lett. 24, 119 (1985)
K. Saotome, H. Morita, M. Umeda, Toxicol. In Vitro 3, 317 (1989)
S.I.A. Wahab et al., J. Biomed. Biotechnol. 769568 (2009)
B.C. Pressman, M. Fashin, Ann. Rev. Pharm. Toxicol. 22, 465 (1982)
K. Nakazato, Y. Hatano, Biochim. Biophys. Acta 1064, 103 (1991)
W.H. Zhu, T T. Loh, Biochim. Biophys. Acta — Mol. Cell Res. 1269, 122 (1995)
S. Grinstein, D. Rotin, M.J. Mason, Biochim. Biophys. Acta 988, 73 (1989)
M. Bental, C. Deutsch, Am. J. Physiol. 266, 541C (1994)
G.N. Rao, N. de Roux, C. Sardet, J. Pouyssegur, B.C. Berk, J. Biol. Chem. 266, 13485 (1991)
J.M. Cobo et al., J. Cell. Physiol. 175, 59 (1998)
S.W. Jacob, In: S.W. Jakob, E.E. Rosenbaun, D.C. Wood (Eds.), Dimethyl sulfoxide, vol. 1. Basic concepts of DMSO (Marcel Dekker Ink., New York, 1971) 99
N.C. Santos, J. Figueira-Coelho, J. Martins-Silva, C. Saldanha, Biochem. Pharm. 65, 1035 (2003)
K.S. Smalley, M. Lioni, M. Herlyn, In Vitro Cell Dev. Biol. — Animal 42, 242 (2006)
J. Lee et al., Small 5, 1213 (2009)
A.C. Souza et al., J. Vet. Med. A — Physiol. Pathol. Clin. Med. 52, 230 (2005)
R. Alexandrova, Exp. Pathol. Parasitol. 4, 57 (2001)
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Alexandrova, R.I., Zhivkova, T., Alexandrov, M. et al. Cytostatic and cytotoxic properties of monensic acid and its biometal(II) complexes against human tumor / non-tumor cell lines. cent.eur.j.chem. 10, 1464–1474 (2012). https://doi.org/10.2478/s11532-012-0071-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11532-012-0071-9